巴西私立机构非瓣膜性心房颤动患者抗凝治疗真实世界研究数据集

数据集获取（Figshare）

• 源站标题：Anticoagulation Therapy in Patients with Non-valvular Atrial Fibrillation in a Private Setting in Brazil: A Real-World Study
• DOI：10.6084/m9.figshare.12094728.v1
• 发布日期：2020-04-08
• 文件数：5 个
• 文件总体积：602.85 KB
• 源站页面：https://scielo.figshare.com/articles/dataset/Anticoagulation_Therapy_in_Patients_with_Non-valvular_Atrial_Fibrillation_in_a_Private_Setting_in_Brazil_A_Real-World_Study/12094728

命令行下载

curl -L -o "0066-782X-abc-20180076-gf01.jpg" "https://ndownloader.figshare.com/files/22240764"
curl -L -o "0066-782X-abc-20180076-gf02.jpg" "https://ndownloader.figshare.com/files/22240767"
curl -L -o "0066-782X-abc-20180076-gf03.jpg" "https://ndownloader.figshare.com/files/22240776"
curl -L -o "Table_1.xls" "https://ndownloader.figshare.com/files/22240782"
curl -L -o "Table_2.xls" "https://ndownloader.figshare.com/files/22240797"

文件清单

• 0066-782X-abc-20180076-gf01.jpg（181.42 KB）
• 0066-782X-abc-20180076-gf02.jpg（276.83 KB）
• 0066-782X-abc-20180076-gf03.jpg（125.14 KB）
• Table_1.xls（9.73 KB）
• Table_2.xls（9.73 KB）

文件总体积 602.85 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Abstract Background: The safety and effectiveness of warfarin depend on anticoagulation control quality. Observational studies associate poor control with increased morbidity, mortality and healthcare costs. Objectives: To develop a profile of non-valvular atrial fibrillation (NVAF) patients treated with warfarin in a Brazilian private ambulatory and hospital setting, evaluate the quality of anticoagulation control, and its association with clinical and economic outcomes. Methods: This retrospective study, through a private health insurance dataset in Brazil, identified NVAF patients treated with warfarin between 01 MAY 2014 to 30 APRIL 2016, described their anticoagulation management, and quantified disease-related costs. Data on demographics, clinical history, concomitant medication and time in therapeutic range (TTR) of international normalized ratio (INR) values were retrieved. Patients were grouped into TTR quartiles, with good control defined as TTR ≥ 65% (Rosendaal method). Major bleeds and all-cause direct medical costs were calculated and compared between good and poor control subgroups. P-values 3), (median TTR: 58%; IQR: 47-68%), (mean TTR: 56.6% ± 18.9%). Only 31% of patients were well-controlled (mean TTR: 78% ± 10%), with 1.6% having major bleeds within median follow-up, and direct medical costs per member per year (PMPY) of R$25,352(± R$ 37,762). Poorly controlled patients (69%) were associated with 3.3 times more major bleeds (5.3% vs. 1.6%; p < 0.01) and 40% higher costs (R$35,384 vs. R$25,352; p < 0.01). Conclusions: More than 60% of the patients were below the desired target and the associated costs were higher.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.6084/m9.figshare.12094728.v1（source: https://scielo.figshare.com/articles/dataset/Anticoagulation_Therapy_in_Patients_with_Non-valvular_Atrial_Fibrillation_in_a_Private_Setting_in_Brazil_A_Real-World_Study/12094728）。